BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6297804)

  • 1. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site?
    Schlegel R; Tralka TS; Willingham MC; Pastan I
    Cell; 1983 Feb; 32(2):639-46. PubMed ID: 6297804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VSV binding to lipids from different cell lines. Brief report.
    Viti D; Sinibaldi L; Superti F; Melucci L; Orsi N
    Arch Virol; 1987; 93(3-4):279-85. PubMed ID: 3030240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells.
    Schlegel R; Willingham MC; Pastan IH
    J Virol; 1982 Sep; 43(3):871-5. PubMed ID: 6292466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralized vesicular stomatitis virus binds to host cells by a different "receptor".
    Schlegel R; Wade M
    Biochem Biophys Res Commun; 1983 Jul; 114(2):774-8. PubMed ID: 6309179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus.
    Coil DA; Miller AD
    J Virol; 2004 Oct; 78(20):10920-6. PubMed ID: 15452212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP-mediated inhibition of vesicular stomatitis virus and herpes simplex virus replication in mouse macrophage-like cells.
    Borghi P; Di Marzio P; Varano B; Conti L; Belardelli F; Gessani S
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2949-54. PubMed ID: 1279103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rat brain cellular membrane components acting as receptors for vesicular stomatitis virus. Brief report.
    Conti C; Mastromarino P; Ciuffarella MG; Orsi N
    Arch Virol; 1988; 99(3-4):261-9. PubMed ID: 2835950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the interaction between vesicular stomatitis virus and phosphatidylserine.
    Carneiro FA; Lapido-Loureiro PA; Cordo SM; Stauffer F; Weissmüller G; Bianconi ML; Juliano MA; Juliano L; Bisch PM; Da Poian AT
    Eur Biophys J; 2006 Jan; 35(2):145-54. PubMed ID: 16184389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vesicular stomatitis virus infection by spike glycoprotein. Evidence for an intracellular, G protein-requiring step.
    Miller DK; Lenard J
    J Cell Biol; 1980 Feb; 84(2):430-7. PubMed ID: 6247355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstituted G protein-lipid vesicles from vesicular stomatitis virus and their inhibition of VSV infection.
    Miller DK; Feuer BI; Vanderoef R; Lenard J
    J Cell Biol; 1980 Feb; 84(2):421-9. PubMed ID: 6247354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH.
    Mastromarino P; Conti C; Goldoni P; Hauttecoeur B; Orsi N
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2359-69. PubMed ID: 2821175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of vesicular stomatitis virus fusion by the endosome-specific phospholipid bis(monoacylglycero)phosphate (BMP).
    Roth SL; Whittaker GR
    FEBS Lett; 2011 Mar; 585(6):865-9. PubMed ID: 21333650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and infectivity of vesicular stomatitis virus containing nonglycosylated G protein.
    Gibson R; Leavitt R; Kornfeld S; Schlesinger S
    Cell; 1978 Apr; 13(4):671-9. PubMed ID: 207437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of vesicular stomatitis (visna virus) pseudotypes to demonstrate visna virus receptors in cells from different species.
    Gilden DH; Devlin M; Wroblewska Z
    Arch Virol; 1981; 67(2):181-5. PubMed ID: 6260064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
    Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
    J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Block of vesicular stomatitis virus endocytic and exocytic pathways by 1-cinnamoyl-3,11-dihydroxymeliacarpin, a tetranortriterpenoid of natural origin.
    Barquero AA; Alché LE; Coto CE
    J Gen Virol; 2004 Feb; 85(Pt 2):483-493. PubMed ID: 14769906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of receptors for vesicular stomatitis virus in vertebrate and invertebrate cells.
    Seganti L; Superti F; Girmenia C; Melucci L; Orsi N
    Microbiologica; 1986 Jul; 9(3):259-67. PubMed ID: 3018449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of vesicular stomatitis virus multiplication in Vero cells by 2-deoxy-D-glucose.
    Sabina LR; Telasco CE
    Acta Virol; 1979 May; 23(3):210-20. PubMed ID: 41433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of matrix protein in assembling the membrane of vesicular stomatitis virus: reconstitution of matrix protein with negatively charged phospholipid vesicles.
    Zakowski JJ; Petri WA; Wagner RR
    Biochemistry; 1981 Jun; 20(13):3902-7. PubMed ID: 6268151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.